IP Library Granted Patent US 11,576,772
Granted Patent B2
US 11,576,772 · App. 16/773,802 · Granted Feb 14, 2023

One-piece heart valve stents adapted for post-implant expansion

Inventors: Visith Chung (Chino, CA); Da-Yu Chang (Irvine, CA); Brian S. Conklin (Orange, CA); Grace Myong Kim (Seal Beach, CA); Louis A. Campbell (Santa Ana, CA); Donald E. Bobo, Jr. (Santa Ana, CA); Myron Howanec, Jr. (Corona, CA); David S. Lin (Irvine, CA); Peng Norasing (Corona, CA); Francis M. Tran (Irvine, CA); Mark Van Nest (Rancho Santa Margarita, CA); Thomas Chien (Irvine, CA); Harvey H. Chen (Irvine, CA); Isidro L. Guerrero (Orange, CA); Derrick Johnson (Orange, CA); Paul A. Schmidt (Irvine, CA)
Assignee: Edwards Lifesciences Corporation
A61F2/2418A61F2/2409A61F2/2445A61F2/2433A61F2210/0004A61F2220/0033A61F2220/0075A61F2230/0054A61F2250/001A61F2250/0004A61F2250/006A61F2250/0063A61F2250/0071A61F2310/00011
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,576,772
App. No.
16/773,802
Granted
Feb 14, 2023
Kind
B2
Abstract

A prosthetic heart valve configured to replace a native heart valve and having a support frame configured to be reshaped into an expanded form in order to receive and/or support an expandable prosthetic heart valve therein is disclosed, together with methods of using same. The prosthetic heart valve may be configured to have a generally rigid and/or expansion-resistant configuration when initially implanted to replace a native valve (or other prosthetic heart valve), but to assume a generally expanded form when subjected to an outward force such as that provided by a dilation balloon or other mechanical expander.

Claims (24)

1. A prosthetic heart valve adapted for post-implant expansion and having an inflow end and an outflow end, comprising:

a one-piece inner structural support stent including a generally circular solid lower band having three upstanding commissure posts, the stent defining an implant circumference that is substantially non-compressible in normal physiological use and has a first diameter, and wherein the lower band is a continuous solid band except for a point of discontinuity around its periphery between adjacent abutting ends of the solid band, the adjacent abutting ends being only separated by a perforated junction defining the point of discontinuity that permits expansion of the support stent from the first diameter to a second diameter larger than the first diameter upon application of an outward dilatory force from within the support stent substantially larger than forces associated with normal physiological use but prevents contraction of the lower band; and

a plurality of flexible leaflets supported by the stent and configured to ensure one-way blood flow therethrough.

2. The prosthetic heart valve of claim 1 , wherein the perforated junction is configured to break upon application of an outward dilatory force from within the support stent of at least 1 atmosphere.

3. The prosthetic heart valve of claim 1 , wherein the perforated junction is configured to resist breaking until application of an outward dilatory force from within the support stent of up to 12 atmospheres.

4. The prosthetic heart valve of claim 1 , wherein each commissure post has a gap between two sides and the lower band extends across the gaps in two wall segments, wherein the point of discontinuity is located where the wall segments come together defining the adjacent abutting ends.

5. The prosthetic heart valve of claim 1 , wherein there is a single point of discontinuity located below only one of the commissure posts.

6. The prosthetic heart valve of claim 1 , wherein there is a point of discontinuity located below each of the commissure posts.

7. The prosthetic heart valve of claim 1 , further including a unique identifier on the support stent visible from outside the body after implant that identifies the support stent as being expandable, and the unique identifier is a numerical valve size in odd 2-millimeter increments between 15-33 mm.

8. The prosthetic heart valve of claim 1 , wherein the one-piece inner structural support stent is made of titanium.

9. The prosthetic heart valve of claim 8 , wherein each commissure post has a gap between two sides and the lower band extends across the gaps in two wall segments, wherein the point of discontinuity is located where the wall segments come together defining the adjacent abutting ends.

10. The prosthetic heart valve of claim 1 , wherein the one-piece inner structural support stent is made of an acetal copolymer.

11. The prosthetic heart valve of claim 10 , wherein each commissure post has a gap between two sides and the lower band extends across the gaps in two wall segments, wherein the point of discontinuity is located where the wall segments come together defining the adjacent abutting ends.

12. A prosthetic heart valve adapted for post-implant expansion and having an inflow end and an outflow end, comprising:

a one-piece inner structural support stent including a generally circular solid lower band having three upstanding commissure posts, the stent defining an implant circumference that is substantially non-compressible in normal physiological use and has a first diameter, and wherein the lower band is a continuous solid band except for a point of discontinuity around its periphery between adjacent ends of the solid band, the adjacent ends being only connected by mutually interlaced tabs defining the point of discontinuity, the interlaced tabs maintaining alignment and circularity of the solid band while being arranged to slide away from one another and permit expansion of the support stent from the first diameter to a second diameter larger than the first diameter upon application of an outward dilatory force from within the support stent substantially larger than forces associated with normal physiological use but preventing contraction of the lower band less than the first diameter; and

a plurality of flexible leaflets supported by the stent and configured to ensure one-way blood flow therethrough.

13. The prosthetic heart valve of claim 12 , wherein each commissure post has a gap between two sides and the lower band extends across the gaps in two wall segments, wherein the point of discontinuity is located where the wall segments come together defining the adjacent ends.

14. The prosthetic heart valve of claim 12 , wherein there is a single point of discontinuity located below only one of the commissure posts.

15. The prosthetic heart valve of claim 12 , wherein there is a point of discontinuity located below each of the commissure posts.

16. The prosthetic heart valve of claim 12 , further including a unique identifier on the support stent visible from outside the body after implant that identifies the support stent as being expandable, and the unique identifier is a numerical valve size in odd 2-millimeter increments between 15-33 mm.

17. The prosthetic heart valve of claim 12 , wherein the one-piece inner structural support stent is made of titanium.

18. The prosthetic heart valve of claim 17 , wherein each commissure post has a gap between two sides and the lower band extends across the gaps in two wall segments, wherein the point of discontinuity is located where the wall segments come together defining the adjacent ends.

19. The prosthetic heart valve of claim 12 , wherein the one-piece inner structural support stent is made of an acetal copolymer.

20. The prosthetic heart valve of claim 19 , wherein each commissure post has a gap between two sides and the lower band extends across the gaps in two wall segments, wherein the point of discontinuity is located where the wall segments come together defining the adjacent ends.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2020
From: CHUNG, VISITH; CHANG, DA-YU; CONKLIN, BRIAN S.; KIM, GRACE MYONG; CAMPBELL, LOUIS A.; BOBO, DONALD E., JR.; HOWANEC, MYRON, JR.; LIN, DAVID S.; NORASING, PENG; TRAN, FRANCIS M.; VAN NEST, MARK; CHIEN, THOMAS; CHEN, HARVEY H.; GUERRERO, ISIDRO L.; JOHNSON, DERRICK; SCHMIDT, PAUL A.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 052553/0757 →
Continuity (6)
Continuation 16007879 · Jun 13, 2018
Continuation In Part 15624427 · Jun 15, 2017
Continuation 15190094 · Jun 22, 2016
Continuation 14136318 · Dec 20, 2013
Provisional Application 61748022 · Dec 31, 2012
Related Publication 20200155309A1 · May 21, 2020